Uncategorized
5-Amino-1MQ (NNMT Inhibitor): The Metabolic Research Compound Guide
5-Amino-1MQ (NNMT Inhibitor): The Metabolic Research Compound Guide
5-Amino-1MQ is a small-molecule NNMT (nicotinamide N-methyltransferase) inhibitor that has become a major focus of metabolic and longevity research. By suppressing NNMT activity, it raises NAD+ availability and drives metabolic pathways toward fat oxidation and energy expenditure. This guide covers its mechanism, research evidence, applications, dosing, and safety.
1. What Is 5-Amino-1MQ?
5-Amino-1MQ is a selective small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), the enzyme that methylates nicotinamide and competes with NAD+ production. NNMT is elevated in obesity and age-related metabolic decline; inhibiting it shifts the balance toward NAD+ preservation and metabolic health. While not a peptide, it is widely sold alongside peptide research compounds and studied in overlapping protocols.
- Compound type: Small-molecule NNMT inhibitor
- Target: Nicotinamide N-methyltransferase
- Administration: Oral (capsule) or subcutaneous injection in research
- Core effects: NAD+ elevation, fat oxidation, energy expenditure
- Status: Research compound
2. Mechanism of Action
5-Amino-1MQ exerts its effects through NNMT inhibition and downstream metabolic reprogramming:
- NNMT inhibition: Blocks methylation of nicotinamide, preserving NAD+ pools
- NAD+ elevation: Increases NAD+ availability for sirtuins and metabolic enzymes
- Fat oxidation: Promotes white adipose tissue browning and fatty acid utilization
- Energy expenditure: Increases thermogenesis and metabolic rate in animal models
3. The Research Landscape
| Research area | Reported findings |
|---|---|
| Obesity models | Reduced fat mass and improved metabolic profile in diet-induced obesity models |
| NAD+ metabolism | Elevated NAD+ levels in target tissues following NNMT inhibition |
| Glucose handling | Improved insulin sensitivity and glucose tolerance in metabolic studies |
| Longevity pathways | Studied as an NAD+-sparing intervention in age-related decline |
5-Amino-1MQ research is early-stage but rapidly expanding, intersecting with the NAD+ and metabolic health fields.
4. Research Applications
- Metabolic research: Obesity, insulin resistance, and lipid metabolism models
- NAD+ research: Alternatives and complements to NMN and NR supplementation
- Thermogenesis research: Brown and beige adipose tissue activation
- Aging research: Metabolic decline and energy homeostasis interventions
For related metabolic research compounds, see our NAD+ research guide and semaglutide guide.
5. Dosing and Protocol Notes
- Common research dose: 50-100 mg/day, oral capsule or subcutaneous injection
- Administration: Daily protocols; injection requires reconstitution
- Reconstitution: Use bacteriostatic water; see our reconstitution and dosage guide
- Cycling: Many research protocols run 8-12 weeks with monitoring of metabolic markers
6. Side Effects and Considerations
- Mild gastrointestinal effects: Nausea or appetite changes reported at higher doses
- Injection site reactions: With subcutaneous administration
- Blood glucose effects: May enhance insulin sensitivity; monitor when combined with hypoglycemic agents
- Limited human data: Most evidence is preclinical; human dosing guidance is empirical
7. Frequently Asked Questions
Is 5-Amino-1MQ a peptide? No — it is a small-molecule NNMT inhibitor, but it is commonly sold and researched alongside peptide compounds.
How does it compare with NMN? NMN provides exogenous NAD+ precursors; 5-Amino-1MQ preserves endogenous NAD+ by blocking a competing enzyme. They are often studied together.
What is the evidence level? Strong preclinical evidence; human clinical data remain limited.
Related Reading
- NAD+ Peptide and Cellular Energy Guide
- Semaglutide Research Guide
- 2026 Peptide Research Trends
- Peptide FAQ: 50 Most Common Questions
Shop Related Research Compounds
Browse our research catalog, including 5-Amino-1MQ, MOTS-c, and NAD+, all supplied with batch COAs.
Disclaimer: This article is for educational and research purposes only. 5-Amino-1MQ is a research compound not approved for general human use. Always consult qualified professionals regarding research protocols.
